Laporan laba rugi Vertex Pharmaceuticals (VRTX)
NASDAQ · Healthcare · Biotechnology · Karyawan: 6.400 · CEO: Reshma Kewalramani
- Harga
- $558,88 +3,50%
- Kapitalisasi pasar
- $142 M
- Nilai perusahaan
- $137 M
- Laporan terakhir
- Q2 '26 diajukan 2026-08-04
- Laporan berikutnya
- 2026-11-02 Estimasi EPS: $4,82
Vertex Pharmaceuticals (VRTX) untuk Q2 '26: pendapatan $3,33 M (+12,5% yoy), laba operasional $1,25 M (37,4% dari pendapatan), laba bersih $1,1 M. Dalam empat kuartal terakhir pendapatan mencapai $12,6 M.
Laporan laba rugi
| Laporan laba rugi | Tren | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pendapatan | $2,48 M | $2,52 M | $2,69 M | $2,65 M | $2,77 M | $2,91 M | $2,77 M | $2,96 M | $3,08 M | $3,23 M | $2,99 M | $3,33 M | |
| Beban pokok pendapatan | $319 jt | $368 jt | $343 jt | $372 jt | $393 jt | $423 jt | $363 jt | $408 jt | $415 jt | $466 jt | $393 jt | $489 jt | |
| Laba kotor | $2,16 M | $2,15 M | $2,34 M | $2,27 M | $2,38 M | $2,49 M | $2,41 M | $2,56 M | $2,66 M | $2,76 M | $2,59 M | $2,84 M | |
| Riset & pengembangan | $862 jt | $1,35 M | $866 jt | $5,42 M | $876 jt | $999 jt | $980 jt | $978 jt | $1,03 M | $974 jt | $962 jt | $994 jt | |
| Beban operasional lainnya | $0 | -$560 jt | -$100 rb | $500 rb | $15,3 jt | $86,3 jt | $401 jt | $3,1 jt | -$1,9 jt | $0 | $700 rb | $21,8 jt | |
| Beban operasional | $1,13 M | $1,16 M | $1,21 M | $5,79 M | $1,26 M | $1,46 M | $1,78 M | $1,41 M | $1,48 M | $1,46 M | $1,46 M | $1,6 M | |
| Laba operasional | $1,04 M | $989 jt | $1,14 M | -$3,51 M | $1,12 M | $1,03 M | $630 jt | $1,15 M | $1,19 M | $1,3 M | $1,14 M | $1,25 M | |
| Pendapatan bunga | $168 jt | $180 jt | $181 jt | $157 jt | $132 jt | $128 jt | $121 jt | $122 jt | $126 jt | $122 jt | $115 jt | $121 jt | |
| Beban bunga | $10,9 jt | $10,6 jt | $10,4 jt | $9,9 jt | $7,5 jt | $2,8 jt | $3 jt | $3,7 jt | $3,3 jt | $3,3 jt | $0 | $0 | |
| Pendapatan non-operasional lainnya (keuntungan investasi, kurs ...) | -$152 jt | -$170 jt | -$150 jt | -$133 jt | -$115 jt | -$113 jt | -$103 jt | -$136 jt | -$116 jt | -$33,9 jt | -$115 jt | -$145 jt | |
| Total pendapatan non-operasional | $141 jt | $159 jt | $140 jt | $124 jt | $108 jt | $111 jt | $100 jt | $132 jt | $113 jt | $30,6 jt | $115 jt | $145 jt | |
| Laba sebelum pajak | $1,18 M | $1,15 M | $1,28 M | -$3,39 M | $1,22 M | $1,14 M | $730 jt | $1,28 M | $1,3 M | $1,33 M | $1,25 M | $1,39 M | |
| Pajak penghasilan | $144 jt | $179 jt | $180 jt | $202 jt | $179 jt | $224 jt | $84,1 jt | $250 jt | $216 jt | $140 jt | $222 jt | $292 jt | |
| Laba bersih | $1,04 M | $969 jt | $1,1 M | -$3,59 M | $1,05 M | $913 jt | $646 jt | $1,03 M | $1,08 M | $1,19 M | $1,03 M | $1,1 M | |
| EPS (dasar) | $4,01 | $3,76 | $4,26 | -$13,92 | $4,05 | $3,55 | $2,52 | $4,02 | $4,24 | $4,69 | $4,06 | $4,33 | |
| EPS (dilusian) | $3,97 | $3,71 | $4,21 | -$13,92 | $4,01 | $3,50 | $2,49 | $3,99 | $4,20 | $4,65 | $4,02 | $4,31 | |
| Saham (dasar, rata-rata tertimbang) | 258 jt | 258 jt | 258 jt | 258 jt | 258 jt | 258 jt | 257 jt | 257 jt | 256 jt | 254 jt | 254 jt | 254 jt | |
| Saham (dilusian, rata-rata tertimbang) | 261 jt | 261 jt | 261 jt | 258 jt | 261 jt | 261 jt | 260 jt | 259 jt | 258 jt | 256 jt | 256 jt | 256 jt | |
| Depresiasi & amortisasi | $42,1 jt | $59 jt | $53,5 jt | $54 jt | $53,2 jt | $46,5 jt | $48,4 jt | $51,7 jt | $54 jt | $55,7 jt | $55,9 jt | $56,5 jt | |
| EBITDA | $1,23 M | $1,22 M | $1,34 M | -$3,33 M | $1,28 M | $1,18 M | $782 jt | $1,34 M | $1,36 M | $1,39 M | $1,31 M | $1,45 M |
| Laporan laba rugi | Tren | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pendapatan | $1,7 M | $2,49 M | $3,05 M | $4,16 M | $6,21 M | $7,57 M | $8,93 M | $9,87 M | $11 M | $12,1 M | |
| Beban pokok pendapatan | $210 jt | $275 jt | $410 jt | $548 jt | $736 jt | $904 jt | $1,08 M | $1,26 M | $1,53 M | $1,81 M | |
| Laba kotor | $1,49 M | $2,21 M | $2,64 M | $3,62 M | $5,47 M | $6,67 M | $7,85 M | $8,61 M | $9,49 M | $10,3 M | |
| Riset & pengembangan | $1,05 M | $1,32 M | $1,42 M | $1,75 M | $1,83 M | $3,05 M | $2,66 M | $3,16 M | $3,63 M | $3,75 M | |
| Penjualan & pemasaran | $31,4 jt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Umum & administrasi | $401 jt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Beban operasional lainnya | $4,13 jt | $0 | -$790 rb | $0 | $13,1 jt | $0 | -$57,5 jt | $476 jt | $4,63 M | $0 | |
| Beban operasional | $1,48 M | $1,82 M | $1,97 M | $2,41 M | $2,61 M | $3,89 M | $3,54 M | $4,78 M | $9,72 M | $5,51 M | |
| Laba operasional | $9,94 jt | $123 jt | $635 jt | $1,2 M | $2,86 M | $2,78 M | $4,31 M | $3,83 M | -$233 jt | $4,76 M | |
| Pendapatan bunga | $0 | $11,7 jt | $0 | $63,7 jt | $22,2 jt | $4,9 jt | $145 jt | $615 jt | $598 jt | $491 jt | |
| Beban bunga | $81,4 jt | $69,3 jt | $34,1 jt | $58,5 jt | $58,2 jt | $61,5 jt | $54,8 jt | $44,1 jt | $30,6 jt | $13,3 jt | |
| Pendapatan non-operasional lainnya (keuntungan investasi, kurs ...) | -$4,13 jt | $69,6 jt | -$37,6 jt | -$256 jt | -$319 jt | -$9,8 jt | $20,2 jt | -$592 jt | -$512 jt | $104 jt | |
| Total pendapatan non-operasional | -$77,3 jt | -$139 jt | -$34,9 jt | $197 jt | $261 jt | -$51,7 jt | -$75 jt | $548 jt | $481 jt | -$118 jt | |
| Laba sebelum pajak | -$67,4 jt | -$15,7 jt | $600 jt | $1,39 M | $3,12 M | $2,73 M | $4,23 M | $4,38 M | $249 jt | $4,64 M | |
| Pajak penghasilan | $16,7 jt | -$107 jt | -$1,49 M | $218 jt | $405 jt | $388 jt | $910 jt | $760 jt | $784 jt | $690 jt | |
| Laba bersih | -$112 jt | $263 jt | $2,1 M | $1,18 M | $2,71 M | $2,34 M | $3,32 M | $3,62 M | -$536 jt | $3,95 M | |
| EPS (dasar) | -$0,46 | $1,06 | $8,25 | $4,58 | $10,44 | $9,09 | $12,97 | $14,05 | -$2,08 | $15,46 | |
| EPS (dilusian) | -$0,46 | $1,04 | $8,09 | $4,51 | $10,29 | $9,01 | $12,82 | $13,89 | -$2,08 | $15,32 | |
| Saham (dasar, rata-rata tertimbang) | 244 jt | 249 jt | 254 jt | 257 jt | 260 jt | 258 jt | 256 jt | 258 jt | 258 jt | 256 jt | |
| Saham (dilusian, rata-rata tertimbang) | 245 jt | 253 jt | 259 jt | 261 jt | 263 jt | 260 jt | 259 jt | 261 jt | 258 jt | 258 jt | |
| Depresiasi & amortisasi | $61,4 jt | $61,4 jt | $72,4 jt | $107 jt | $110 jt | $126 jt | $148 jt | $181 jt | $207 jt | $210 jt | |
| EBITDA | $75,5 jt | $103 jt | $707 jt | $1,56 M | $3,28 M | $2,92 M | $4,44 M | $4,61 M | $486 jt | $4,87 M |
Distandardisasi oleh Financial Modeling Prep dari laporan perusahaan; arus keluar dan biaya mempertahankan tanda yang dilaporkan penyedia. Arahkan kursor ke periode untuk melihat tanggal berakhirnya. Jumlah dalam USD.
Pendapatan, laba operasional, dan pertumbuhan
kuartalanMargin
kuartalanBiaya sebagai % pendapatan
kuartalanLaporan lainnya
Sumber
Laporan keuangan, pendapatan segmen, metrik, estimasi: Financial Modeling Prep. Laba segmen dan setiap pos yang dilaporkan: SEC EDGAR (XBRL). Laporan yang dibaca: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data per 2026-11-01